Currently, there is no antioxidant indicated for any CV disease [except for dexrazoxane in anthracycline toxicity (252) which can produce severe adverse effects and its use is limited(ref)] due to few and small clinical trials which were not necessarily following the results from preclinical studies
In addition, the cytotoxicity of MSCm, NanoSU6668, MNS, and T-MNS to the primary rat corneal endothelial cells (CECs) and human corneal epithelial cells (HCEs) were also tested
evening dosing has been linked to sleep disruption because of the metabolic activation effect
di Villa Bianca Rd, Cirino G, Sorrentino R
DSIPs regulatory influence on hormonal balance and stress pathways positions it as a promising option in peptide therapy to address sleep disturbances and associated conditions, improving quality of life and overall well-being
Phentermine-topiramate (Qsymia) Topiramate, long used for seizure disorders and chronic migraine headache, was approved for obesity treatment in an extended-release combination with phentermine in 2012